Is monoclonal antibody administration necessary in all vaccinated patients with breakthrough COVID-19 infections?

Lanzafame, M; Gibbin, E; Lattuada, E; Vento, S

doi:10.1002/jmv.27802

Is monoclonal antibody administration necessary in all vaccinated patients with breakthrough COVID-19 infections? / Lanzafame, M; Gibbin, E; Lattuada, E; Vento, S. - In: JOURNAL OF MEDICAL VIROLOGY. - ISSN 1096-9071. - 94:8(2022), pp. 3515-3516. [10.1002/jmv.27802]

Is monoclonal antibody administration necessary in all vaccinated patients with breakthrough COVID-19 infections?

Lanzafame M;Gibbin E;Lattuada E;Vento S

2022-01-01

Scheda breve

Scheda completa

Scheda completa (DC)

	Anno di pubblicazione (Date of publication)
	
				2022
			
	Titolo del periodico (Journal title)
	
				JOURNAL OF MEDICAL VIROLOGY
			
	Numero e parte del fascicolo (Issue number and part)
	
				8
			
	DOI
	
				https://dx.doi.org/10.1002/jmv.27802
			
	Codice PubMed (PubMed Identifier)
	
				35451105
			
	Codice Scopus (Scopus identifier)
	
				2-s2.0-85128925915
			
	Codice WOS (WOS identifier)
	
				WOS:000788265300001
			
	Tutti gli autori
	
						Lanzafame, M; Gibbin, E; Lattuada, E; Vento, S
					
	Citazione
	
				Is monoclonal antibody administration necessary in all vaccinated patients with breakthrough COVID-19 infections? / Lanzafame, M; Gibbin, E; Lattuada, E; Vento, S. - In: JOURNAL OF MEDICAL VIROLOGY. - ISSN 1096-9071. - 94:8(2022), pp. 3515-3516. [10.1002/jmv.27802]
			
	Appare nelle tipologie:
	
				03.1 Articolo su rivista (Journal article)

File in questo prodotto:

File	Dimensione	Formato
J med virol 2022.pdf Solo gestori archivio Tipologia: Versione editoriale (Publisher’s layout) Licenza: Tutti i diritti riservati (All rights reserved) Dimensione 392.55 kB Formato Adobe PDF Visualizza/Apri	392.55 kB	Adobe PDF	Visualizza/Apri